Sl. Oconnell et al., EFFECTS OF PREDNISOLONE AND DEFLAZACORT ON OSTEOCALCIN METABOLISM IN SHEEP, Calcified tissue international, 53(2), 1993, pp. 117-121
Glucocorticoids adversely affect bone and mineral metabolism through a
number of mechanisms, including inhibition of bone formation. Deflaza
cort is a glucocorticoid which has been reported to be relatively ''bo
ne-sparing.'' We compared the effects in oophorectomized sheep of defl
azacort and prednisolone on the metabolism of osteocalcin (OC), a mark
er of osteoblast function. An [I-125]OC infusion method was used to me
asure the OC plasma clearance rate (PCR) and OC plasma production rate
(PPR). Six-day intravenous infusion of deflazacort and prednisolone (
in the dose range 0.007-1.00 mg/hour) induced dose-dependent decreases
in OC PPR which were of a similar pattern but significantly different
magnitude (P < 0.02); deflazacort demonstrated a potency about 150% t
hat of prednisolone. Both steroids decreased plasma OC levels on a dos
e-related basis but at the lower doses 0.05 mg/hour (P < 0.05) and 0.0
13 mg/hour (P < 0.0005), deflazacort caused greater decrements. OC PCR
was significantly increased only by higher doses of deflazacort (1.00
mg/hour, 0.25 mg/hour; P < 0.05). Deflazacort and prednisolone increa
sed both postabsorptive plasma glucose and plasma calcium levels, but
there were no significant differences between their effects. We conclu
de that plasma OC levels and OC PPR in sheep were more sensitive to th
e effects of deflazacort than to prednisolone. At high doses, the depr
essive effect of deflazacort on plasma OC levels may have been due in
part to an increased OC PCR which was not evident with prednisolone tr
eatment. However, the agents appeared to have a similar dose-dependent
hyperglycemic effect, and both caused a small dose-dependent increase
in plasma calcium. These findings indicate that prednisolone had simi
larly potent effects on both bone and glucose metabolism while deflaza
cort exhibited differential potency on the two systems. The greater po
tency of deflazacort on bone in sheep may be due to species difference
s in steroid metabolism or steroid-receptor interaction.